Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-17-010280
Filing Date
2017-02-22
Accepted
2017-02-22 06:03:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 v460092_424b5.htm 424B5 982249
2 GRAPHIC logo_424b5.jpg GRAPHIC 13112
3 GRAPHIC tlogo.jpg GRAPHIC 7932
  Complete submission text file 0001144204-17-010280.txt   1012428
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 424B5 | Act: 33 | File No.: 333-194338 | Film No.: 17626977
SIC: 2834 Pharmaceutical Preparations